CorMedix CRMD
NASDAQ CRMD
$7.70 -0.23 (-2.90%)
As of: Sep 30, 2026 · 2:24 PM EDT

CorMedix (CRMD) EPS (Diluted) (2014 - 2026)

Updated

CorMedix's EPS (Diluted) was $0.28 in Q2 2026, up 1.9% from $0.28 a year earlier.

Analysis

CorMedix (CRMD) EPS (Diluted) (2014 - 2026) Analysis & Trends

On a trailing twelve-month basis, CorMedix's EPS (Diluted) was $1.80 through Jun 30, 2026, up 153.5% year-over-year; for FY2025, it was $2.03.

  • In earlier years, EPS (Diluted) was -$0.30 in FY2024, -$0.91 in FY2023, -$0.74 in FY2022 and -$0.75 in FY2021.
  • Quarterly EPS (Diluted) has moved between -$0.29 (Q4 2023) and $1.26 (Q3 2025) over five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Diluted) (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 2.27
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 2.04
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn -0.54
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn 1.67
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn 1.85
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 4.37
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn -8.44
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn -0.04
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 4.31
10 CorMedix 615.90 Mn -36.62 Mn 77.13 Mn 0.28
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 0.28
Dec 31, 2025 0.15
Sep 30, 2025 1.26
Jun 30, 2025 0.28
Mar 31, 2025 0.30
Dec 31, 2024 0.23
Sep 30, 2024 -0.05
Jun 30, 2024 -0.25
Mar 31, 2024 -0.25
Dec 31, 2023 -0.29
Sep 30, 2023 -0.17
Jun 30, 2023 -0.25
Mar 31, 2023 -0.24
Dec 31, 2022 -0.20
Sep 30, 2022 -0.17
Jun 30, 2022 0.19
Mar 31, 2022 0.18
Dec 31, 2021 -0.21
Sep 30, 2021 0.23
Jun 30, 2021 0.12
API Access

CorMedix EPS (Diluted) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=eps-diluted&ticker=CRMD&period=max&api_key=YOUR_API_KEY